Moneycontrol PRO
Loans
HomeNewsMahantesh sabarad

Mahantesh Sabarad

Jump to
  • Auto, FMCG, consumer durables to benefit from GST: SBICap

    Mahantesh Sabarad of SBICap Securities believes various sectors will be impacted by the rate of Goods and Services Tax (GST), expected to be around 18 percent.

  • US elections pose risks to pharma sector: SBICap

    US elections pose risks to pharma sector: SBICap

    The entire business model of pharma companies in the US comprising of substantial filings, inspection of facilities & FDA compliance and marketing distributing strategy is threatened at present, says Mahantesh Sabarad, Deputy VP Research, SBICap Securities.

  • Look at Allcargo Logistics, says Mahantesh Sabarad

    Look at Allcargo Logistics, says Mahantesh Sabarad

    Mahantesh Sabarad of SBICAP Securities is of the view that one may look at Allcargo Logistics.

  • Dish TV looks attractive, says Mahantesh Sabarad

    Dish TV looks attractive, says Mahantesh Sabarad

    Mahantesh Sabarad of SBICAP Securities is of the view that Dish TV is looking attractive.

  • YES Bank may move to Rs 1050-1060: Mahantesh Sabarad

    YES Bank may move to Rs 1050-1060: Mahantesh Sabarad

    Mahantesh Sabarad of SBICAP Securities feels that YES Bank may move to Rs 1050-1060.

  • Look at Maruti Suzuki, says Mahantesh Sabarad

    Look at Maruti Suzuki, says Mahantesh Sabarad

    Mahantesh Sabarad of SBICAP Securities is of the view that one may look at Maruti Suzuki.

  • Buy United Breweries, says Mahantesh Sabarad

    Buy United Breweries, says Mahantesh Sabarad

    Mahantesh Sabarad of SBICAP Securities suggests buying United Breweries.

  • Buy Nestle India, says Mahantesh Sabarad

    Buy Nestle India, says Mahantesh Sabarad

    Mahantesh Sabarad of SBICAP Securities is of the view that one may buy Nestle India.

  • Bullish on overall mkt; like Nestle, Maruti, Yes Bank:SBICAP Sec

    Bullish on overall mkt; like Nestle, Maruti, Yes Bank:SBICAP Sec

    Stock specific Mahantesh Sabarad of SBICAP Securities is very bullish on Nestle India and Maruti and have target price of Rs 6800 and Rs 4900 respectively.

  • Here are some top trading ideas from Mahantesh Sabarad

    Here are some top trading ideas from Mahantesh Sabarad

    Watch the interview of Mahantesh Sabarad of SBICap Securities with Anuj Singhal & Ekta Batra on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.

  • Cautious on pharma space, says Mahantesh Sabarad

    Cautious on pharma space, says Mahantesh Sabarad

    Mahantesh Sabarad, Deputy VP-Research, SBICap Securities has a cautious view on the pharma space.

  • Like JK Tyre and Industries: Mahantesh Sabarad

    Like JK Tyre and Industries: Mahantesh Sabarad

    Mahantesh Sabarad, Deputy VP-Research, SBICap Securities likes JK Tyre and Industries from the tyre space.

  • Here are some stock picks from Mahantesh Sabarad

    Here are some stock picks from Mahantesh Sabarad

    Watch the interview of Mahantesh Sabarad, Deputy VP-Research, SBICap Securities with Ekta Batra and Anuj Singhal on CNBC-TV18, in which he shared his reading and outlook on market and specific stocks.

  • Like Maruti, Hero Moto may test Rs 2800: Mahantesh Sabarad

    Like Maruti, Hero Moto may test Rs 2800: Mahantesh Sabarad

    Mahantesh Sabarad, Deputy Vice President - Research at SBI Capital Securities likes Maruti Suzuki with a target of Rs 5100 and has a target of Rs 2800 for Hero Motocorp.

  • Prefer Power Grid: Mahantesh Sabarad

    Prefer Power Grid: Mahantesh Sabarad

    Mahantesh Sabarad, Deputy Vice President - Research at SBI Capital Securities is of the view that one may prefer Power Grid.

  • Like Jubilant Life Sciences, says Mahantesh Sabarad

    Like Jubilant Life Sciences, says Mahantesh Sabarad

    Mahantesh Sabarad, Deputy Vice President - Research at SBI Capital Securities likes Jubilant Life Sciences.

  • Mkt downside capped between 7800-8000; like cement: SBICap

    Mkt downside capped between 7800-8000; like cement: SBICap

    Amongst the cement companies, Mahantesh Sabarad of SBICap Securities prefers regional players that are exposed to central and eastern parts of the country than largecap names. He likes Heidelberg from that space

  • HeidelbergCement favourite in cement space: SBI Cap

    HeidelbergCement favourite in cement space: SBI Cap

    Mahantesh Sabarad, Deputy VP-Research at SBI Capital Securities is of the view that HeidelbergCement India is the favourite in the cement space.

  • Nestle attractive now; buy Oberoi Realty: SBICap Securities

    Nestle attractive now; buy Oberoi Realty: SBICap Securities

    Watch the interview of Mahantesh Sabarad, Dy VP-Research at SBICap Securities with Anuj Singhal & Ekta Batra on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.

  • Valuations attractive now; like banking, infra: SBICap

    Valuations attractive now; like banking, infra: SBICap

    Sabarad of SBICap Securities is bullish on the infrastructure and banking themes, and wary of auto-ancillary firms with sizeable exposure to European markets.

  • Look at GlaxoSmithKline Consumer: Mahantesh Sabarad

    Look at GlaxoSmithKline Consumer: Mahantesh Sabarad

    Mahantesh Sabarad, Deputy VP - Research at SBI Capital Securities is of the view that one may look at GlaxoSmithKline Consumer Healthcare.

  • Prefer Allcargo Logistics, look at Dish TV: SBI Capital Sec

    Prefer Allcargo Logistics, look at Dish TV: SBI Capital Sec

    Mahantesh Sabarad, Deputy VP - Research at SBI Capital Securities is of the view that one may prefer Allcargo Logistics and feels that one may look at Dish TV.

  • Buy Infosys, says Mahantesh Sabarad

    Buy Infosys, says Mahantesh Sabarad

    Mahantesh Sabarad, Deputy VP - Research at SBI Capital Securities is of the view that one can buy Infosys.

  • Tata Motors appears attractive, says Mahantesh Sabarad

    Tata Motors appears attractive, says Mahantesh Sabarad

    Mahantesh Sabarad, Deputy VP - Research at SBI Capital Securities is of the view that Tata Motors appears attractive.

  • Positive on fin NBFCs, select pharma cos: SBICap Sec

    Positive on fin NBFCs, select pharma cos: SBICap Sec

    Mahantesh Sabarad of SBICAP Securities is bullish on financial NBFC space, select pharma companies and IT stocks. He likes PTC India, Dr Reddy's Lab, Biocon, Infosys and Firstsource, among others.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347